AU2003201641A8 - Treatment and diagnosis of af4-dependant diseases - Google Patents
Treatment and diagnosis of af4-dependant diseasesInfo
- Publication number
- AU2003201641A8 AU2003201641A8 AU2003201641A AU2003201641A AU2003201641A8 AU 2003201641 A8 AU2003201641 A8 AU 2003201641A8 AU 2003201641 A AU2003201641 A AU 2003201641A AU 2003201641 A AU2003201641 A AU 2003201641A AU 2003201641 A8 AU2003201641 A8 AU 2003201641A8
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- treatment
- dependant
- diseases
- dependant diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Marine Sciences & Fisheries (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0200531A GB0200531D0 (en) | 2002-01-09 | 2002-01-09 | New use |
GB0200531.2 | 2002-01-09 | ||
GB0200737A GB0200737D0 (en) | 2002-01-11 | 2002-01-11 | New use |
GB0200737.5 | 2002-01-11 | ||
PCT/GB2003/000041 WO2003057240A2 (en) | 2002-01-09 | 2003-01-07 | Treatment and diagnosis of af4-dependant diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003201641A1 AU2003201641A1 (en) | 2003-07-24 |
AU2003201641A8 true AU2003201641A8 (en) | 2003-07-24 |
Family
ID=26246932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003201641A Abandoned AU2003201641A1 (en) | 2002-01-09 | 2003-01-07 | Treatment and diagnosis of af4-dependant diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003201641A1 (en) |
WO (1) | WO2003057240A2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026930A1 (en) * | 1993-05-14 | 1994-11-24 | Thomas Jefferson University | Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities |
-
2003
- 2003-01-07 WO PCT/GB2003/000041 patent/WO2003057240A2/en not_active Application Discontinuation
- 2003-01-07 AU AU2003201641A patent/AU2003201641A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003201641A1 (en) | 2003-07-24 |
WO2003057240A3 (en) | 2003-09-25 |
WO2003057240A2 (en) | 2003-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003290548A8 (en) | Prevention and treatment of synucleinopathic disease | |
HUP0401127A3 (en) | Treatment and diagnosis of macrophage disease | |
EP1551990A4 (en) | Diagnosis and treatment of chemoresistant tumors | |
AU2002367535A8 (en) | Diagnosis and treatment of vascular disease | |
IL162201A0 (en) | New methods for diagnosis and treatment of tumours | |
EP1553912A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003268531A8 (en) | Materials and methods for treatment of allergic diseases | |
IL166016A0 (en) | Topical treatment of skin diseases | |
AU2003268295A8 (en) | "diagnosis and treatment of infertility" | |
AU2003291536A8 (en) | Method for the diagnosis and treatment of vascular disease | |
AU2003233681A8 (en) | Diagnosis and treatment of human dormancy syndrome | |
GB0211295D0 (en) | Treatment of pain | |
AU2003210266A8 (en) | Treatment, diagnosis and imaging of disease | |
EP1773882A4 (en) | Diagnosis and treatment of siglec-6 associated diseases | |
AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU2003245858A8 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
GB9908059D0 (en) | Diagnosis and treatment of diseases | |
GB0316940D0 (en) | Treatment of skin and other medical conditions | |
AU2003201641A8 (en) | Treatment and diagnosis of af4-dependant diseases | |
AU2002364889A8 (en) | Methods for diagnosis and treatment of diseases associated with altered expression of nrf2 | |
AU2003235665A8 (en) | Diagnostic and therapeutic uses of topors | |
AU2003237143A8 (en) | Diagnosis and treatment of glaucoma | |
AU2003297570A1 (en) | Treatment of skin diseases | |
AU2002365654A8 (en) | Treatment of diseases via the skin | |
AU2002952346A0 (en) | Diagnosis and treatment of disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |